MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

17 Jan 2022 Evaluate
The sales surged to Rs. 1015.92 millions, up 33.38% for the December 2021 quarter as against Rs. 761.67 millions during the corresponding quarter previous year.Modest increase of 12.28% in the Net Profit was reported from. 199.75 millions to Rs. 224.28  millions.The company reported a good operating profit of 278.39 millions compared to 240.75 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 1015.92 761.67 33.38 1015.92 761.67 33.38 1015.92 761.67 33.38
Other Income 50.81 7.58 570.32 50.81 7.58 570.32 50.81 7.58 570.32
PBIDT 278.39 240.75 15.63 278.39 240.75 15.63 278.39 240.75 15.63
Interest 9.88 11.09 -10.91 9.88 11.09 -10.91 9.88 11.09 -10.91
PBDT 268.51 229.66 16.92 268.51 229.66 16.92 268.51 229.66 16.92
Depreciation 20.76 15.89 30.65 20.76 15.89 30.65 20.76 15.89 30.65
PBT 247.75 213.77 15.90 247.75 213.77 15.90 247.75 213.77 15.90
TAX 23.47 14.02 67.40 23.47 14.02 67.40 23.47 14.02 67.40
Deferred Tax -24.51 -3.24 656.48 -24.51 -3.24 656.48 -24.51 -3.24 656.48
PAT 224.28 199.75 12.28 224.28 199.75 12.28 224.28 199.75 12.28
Equity 221.65 80.35 175.86 221.65 80.35 175.86 221.65 80.35 175.86
PBIDTM(%) 27.40 31.61 -13.30 27.40 31.61 -13.30 27.40 31.61 -13.30
Peers
Company Name CMP
Godrej Industries 1063.65
SRF 2469.60
BASF India 3477.55
Pidilite Inds. 1476.00
Tata Chemicals 622.65
View more..